Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Inspire Medical Systems stock have an average target of 228.82, with a low estimate of 190 and a high estimate of 260. The average target predicts an increase of 25.42% from the current stock price of 182.44.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$190	$228.82	$234	$260
Change	+4.14%	+25.42%	+28.26%	+42.51%

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	2	2	3	3	3	3
Buy	6	6	5	5	5	5
Hold	4	4	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Richard Newitter Truist Securities	Truist Securities	Strong Buy Maintains $250 → $235	Strong Buy	Maintains	$250 → $235	+28.81%	Feb 11, 2025
Shagun Singh RBC Capital	RBC Capital	Buy Reiterates $260	Buy	Reiterates	$260	+42.51%	Feb 11, 2025
Mike Polark Baird	Baird	Buy Maintains $252 → $248	Buy	Maintains	$252 → $248	+35.94%	Feb 11, 2025
Larry Biegelsen Wells Fargo	Wells Fargo	Hold Maintains $198 → $195	Hold	Maintains	$198 → $195	+6.88%	Feb 11, 2025
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Buy Maintains $230 → $220	Buy	Maintains	$230 → $220	+20.59%	Feb 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

968.58M

Increased by 20.65%

from 802.80M

Revenue Next Year

1.14B

Increased by 17.49%

from 968.58M

EPS This Year

2.21

Increased by 26.31%

from 1.75

EPS Next Year

3.26

Increased by 47.46%

from 2.21

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	115.38M	233.39M	407.86M	624.80M	802.80M	968.58M	1.14B	1.33B
Revenue Growth	40.62%	102.28%	74.75%	53.19%	28.49%	20.65%	17.49%	16.43%
EPS	-2.19	-1.54	-1.60	-0.72	1.75	2.21	3.26	4.70
EPS Growth	-	-	-	-	-	26.31%	47.46%	44.05%
Forward PE	-	-	-	-	-	82.54	55.97	38.86
No. Analysts	-	-	-	-	-	21	20	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1.0B	1.2B	1.4B
Avg	968.6M	1.1B	1.3B
Low	921.2M	1.1B	1.2B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	25.3%	24.6%	25.7%
Avg	20.6%	17.5%	16.4%
Low	14.7%	10.0%	6.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	2.34	4.67	6.53
Avg	2.21	3.26	4.70
Low	2.06	2.65	3.79

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	33.8%	111.4%	100.4%
Avg	26.3%	47.5%	44.1%
Low	17.6%	19.7%	16.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.